Today, Select Medical Holdings Corp. (SEM) Issues FY16 Earnings Guidance

Today, Select Medical Holdings Corp. (SEM) Issues FY16 Earnings Guidance

Select Medical Holdings Corp. (NYSE:SEM) issued an update on its FY16 earnings guidance on Tuesday morning. The company provided EPS guidance of $0.80-0.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.65. The company issued revenue guidance of $4.25-4.30 billion, compared to the consensus revenue estimate of $4.29 billion.

Shares of Select Medical Holdings Corp. (NYSE:SEM) opened at 12.70 on Tuesday. The firm has a 50-day moving average of $12.72 and a 200 day moving average of $12.15. The firm has a market capitalization of $1.68 billion, a price-to-earnings ratio of 13.51 and a beta of 1.07. Select Medical Holdings Corp. has a 52 week low of $7.33 and a 52 week high of $14.30.

Select Medical Holdings Corp. (NYSE:SEM) last posted its quarterly earnings data on Thursday, November 3rd. The company reported $0.06 EPS for the quarter, missing the Zacks’ consensus estimate of $0.15 by $0.09. Select Medical Holdings Corp. had a net margin of 2.91% and a return on equity of 9.53%. The firm earned $1.05 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the prior year, the company posted $0.22 earnings per share. The company’s revenue for the quarter was up 3.2% compared to the same quarter last year. On average, equities analysts predict that Select Medical Holdings Corp. will post $0.68 earnings per share for the current fiscal year.

A number of research firms have recently commented on SEM. Zacks Investment Research lowered shares of Select Medical Holdings Corp. from a hold rating to a sell rating in a research note on Thursday, October 6th. JMP Securities lowered shares of Select Medical Holdings Corp. from a market perform rating to an underperform rating and set a $10.00 price objective on the stock. in a research note on Wednesday, September 28th.

In related news, insider David S. Chernow sold 90,164 shares of the stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $12.11, for a total transaction of $1,091,886.04. Following the transaction, the insider now directly owns 1,010,453 shares of the company’s stock, valued at $12,236,585.83. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider David S. Chernow sold 50,000 shares of the stock in a transaction on Friday, September 30th. The stock was sold at an average price of $13.51, for a total transaction of $675,500.00. Following the transaction, the insider now directly owns 799,075 shares in the company, valued at $10,795,503.25. The disclosure for this sale can be found here. Corporate insiders own 19.63% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of SEM. Price T Rowe Associates Inc. MD raised its position in shares of Select Medical Holdings Corp. by 14.8% in the third quarter. Price T Rowe Associates Inc. MD now owns 17,769,860 shares of the company’s stock valued at $239,893,000 after buying an additional 2,285,267 shares in the last quarter. BlackRock Fund Advisors increased its position in Select Medical Holdings Corp. by 2.9% in the second quarter. BlackRock Fund Advisors now owns 7,394,101 shares of the company’s stock valued at $80,374,000 after buying an additional 211,316 shares during the last quarter. BlackRock Institutional Trust Company N.A. increased its position in Select Medical Holdings Corp. by 2.8% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 2,618,002 shares of the company’s stock valued at $28,458,000 after buying an additional 70,222 shares during the last quarter. Northern Trust Corp increased its position in Select Medical Holdings Corp. by 3.7% in the third quarter. Northern Trust Corp now owns 1,914,591 shares of the company’s stock valued at $25,848,000 after buying an additional 67,473 shares during the last quarter. Finally, Marshall Wace LLP increased its position in Select Medical Holdings Corp. by 14.8% in the second quarter. Marshall Wace LLP now owns 1,087,452 shares of the company’s stock valued at $11,821,000 after buying an additional 140,084 shares during the last quarter. 82.45% of the stock is currently owned by institutional investors and hedge funds.

About Select Medical Holdings Corp.

Related posts

Leave a Comment